TG Therapeutics (NASDAQ:TGTX) Rating Increased to Hold at StockNews.com

TG Therapeutics (NASDAQ:TGTX – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. A number of other equities analysts have also issued reports on the company. HC Wainwright raised their price target on TG Therapeutics from $49.00 to $55.00 and gave the stock […]

Leave a Reply

Your email address will not be published.

Previous post Joe Mazzulla has blunt reaction to Jerod Mayo’s Patriots firing
Next post Credit Acceptance (NASDAQ:CACC) Cut to Hold at StockNews.com